BDBM620360 US20230295182, Example 2.10::ethyl ((5r,8R)-3-(((2R,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-methoxy- 4-(4-(2,3,4-trifluorophenyl)-1H-1,2,3-triazol-1-yl)tetrahydro-2H-pyran-2- yl)methyl)-1-oxa-2-azaspiro[4.5]dec-2-en-8-yl)carbamate

SMILES CCOC(=O)N[C@H]1CC[C@@]2(CC(C[C@H]3O[C@H](CO)[C@H](O)[C@@H]([C@H]3OC)n3cc(nn3)-c3ccc(F)c(F)c3F)=NO2)CC1

InChI Key InChIKey=TZKUCRKOXCWXEI-KUAYZRFQSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 620360   

TargetGalectin-1(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM620360(US20230295182, Example 2.10 | ethyl ((5r,8R)-3-(((...)
Affinity DataIC50:  320nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384 well plates are supplemented with 22.8 uL/well of biotinylated hG...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM620360(US20230295182, Example 2.10 | ethyl ((5r,8R)-3-(((...)
Affinity DataIC50:  20nMAssay Description:Briefly, compounds are serially diluted in DMSO (working dilutions). ASF-coated 384 well plates are supplemented with 22.8 uL/well of biotinylated hG...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent